Miami (August 28, 2025) – Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved ...
The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...
Nonmedication COPD strategies, such as pulmonary rehabilitation, are highlighted. Jeffrey D. Dunn, PharmD, MBA: [Summarize] the nonmedication strategies that we can use to optimize the management of ...
Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts. Reynold Panettieri Jr, MD: I tend to escalate pretty [early] ...
This guidance provides strategies that optimise chronic obstructive pulmonary disease (COPD) care across the pathway and offer integrated care boards a consistent methodology and set of strategies for ...
Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results